Contrast-enhanced MRI shines light on liver cancer survival
Uptake of a hepatobiliary MR contrast agent helps predict tumour aggressiveness and recurrence-free survival in patients with liver cancer
Read article: Contrast-enhanced MRI shines light on liver cancer survival